Skip to Main Navigation
Skip to Page Content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/7604

1,2-Propylene oxide: Target Organs and Levels of Evidence for TR-267

Toxicology and Carcinogenesis Studies of Propylene Oxide (CASRN 75-56-9) in F344/N Rats and B6C3F1 Mice (Inhalation Studies)

Chemical (Study Title)
CASRN
Peer Review DateRoute/Exposure LevelsStudy Laboratory
1,2-Propylene oxide
75-56-9
06/29/1983Inhalation
0,200,400 PPM/50 PER GROUP
Battelle Northwest Laboratory

Levels of Evidence

Male Rats: Some Evidence
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Nasal Cavity: ADENOMA 0/50 0/50 2/50
Non-Neoplastic Lesions
  • NASAL CAVITY: INFLAMMATION, SUPPURATIVE; HYPERPLASIA, EPITHELIAL; METAPLASIA, SQUAMOUS
Female Rats: Some Evidence
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Nasal Cavity: ADENOMA 0/50 0/50 3/50
Non-Neoplastic Lesions
  • NASAL CAVITY: INFLAMMATION, SUPPURATIVE; HYPERPLASIA, EPITHELIAL; METAPLASIA, SQUAMOUS
Male Mice: Clear Evidence
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Vascular System (Nasal Cavity): HEMANGIOMA 0/50 0/50 5/50; HEMANGIOSARCOMA 0/50 0/50 5/50
Non-Neoplastic Lesions
  • NASAL CAVITY: INFLAMMATION, SUPPURATIVE
Female Mice: Clear Evidence
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Vascular System (Nasal Cavity): HEMANGIOMA 0/50 0/50 3/50; HEMANGIOSARCOMA 0/50 0/50 2/50
Non-Neoplastic Lesions
  • NASAL CAVITY: INFLAMMATION, SUPPURATIVE